AD MSL/Medical Science Liaison - Oncology - Mountain West (Denver, Phoenix) CO, AZ, NM, KS, OK, WY
Boehringer Ingelheim
Summary
The Medical Science Liaison is part of a regional therapeutic area MSL team within Field Based Medicine (FBM), reporting into the MSL Sr AD. The focus of this role is field-based scientific exchange (SE), leveraging scientific background, industry knowledge, and business acumen to act as a scientific resource to scientific experts (SCEs) while gathering insights that inform Scientific Objectives (SOs) and strategic decision making by Medicine.
Job description
Customer Interactions and Scientific Exchange
- Proactively conduct scientific exchange with SCEs to support the SOs.
- Establish and maintain scientific relationships with SCEs while developing a strong understanding of territory-specific healthcare systems and clinical practices related to patient care, disease management, treatment protocols, and research interests.
- Act as a scientific resource to SCEs and HCPs to reactively answer specific questions on TA or disease state topics and BI compounds through scientific exchange.
- Provide disease state education on topics related to TA Scientific Objectives.
- Act as a scientific resource to Scientific Experts at payer accounts and integrated delivery networks when requested.
Planning and Support
- Proactively develop a territory-specific medical engagement plan for scientific exchange with prioritized SCEs supporting the TA Scientific Objectives and priorities.
- Proactively assess SCEs appropriate to interact with as part of the medical engagement plan.
- Identify and communicate challenging gaps between BIPI and customer expectations, needs, and priorities.
- Proactively monitor and adjust tactical medical engagement plan to better achieve TA Scientific Objectives.
- Support identification and assist with development of scientific materials required to effectively conduct scientific exchange.
- Support identification of training needs to effectively engage in scientific exchange.
- Maintain regular communication with the TA MSL Team to review ongoing activities and insights, share best practices, and communicate learnings.
- Interact with current and potential BI study investigators to support clinical trial activities in alignment with Clinical Operations.
- Facilitate logistical communications between BIPI and HCPs regarding Investigator Initiated Studies (IIS), External Collaborative Research, company study contracts, etc.
- Provide additional scientific support for Medicine and Scientific Affairs activities, including support for scientific congresses and medical information.
- Maintain clinical, scientific, and technical expertise in specific TA through continuous learning and knowledge of TA-related scientific literature.
Insight Generation and Reporting
- Identify, document, discuss, and communicate scientific insights as guided by the TA Scientific Objectives.
- Document field-generated scientific insights within appropriate systems and communicate to appropriate internal stakeholders.
- Participate in the discussion of scientific insights gathered by the TA MSL team to understand breadth of insights, potential impact, and stimulate scientific exploration.
- Support communication of scientific insights across the Medical and Commercial organizations.
- Identify changes in the healthcare landscape and trends impacting delivery within the territory.
Collaboration
- Collaborate within the TA MSL Team on all aspects of planning, execution, sharing of best practices, and insight generation.
- Collaborate to provide field-based scientific expertise for key accounts.
- Learn about new and evolving customers and the changing medical needs of such customers.
- Collaborate with Commercial personnel in a compliant manner to provide scientific support for internal and external activities.
- Collaborate with CDMA and the broader Medicine organization to provide scientific support and communicate scientific insights.
Requirements
- BSc required
- Advanced science/clinical degree with 3+ years' relevant experience (preferred)
- Masters in health sciences with 5+ years' experience
- BSc with MBA or BSN with MBA and 7+ years' experience
- PA with 5+ years' experience
- Other medical licensure with 9+ years of experience
- 2 or more years of experience as an MSL or comparable field-based scientific or medical role
- Experience leading field-based medicine or medical affairs projects or mentoring MSLs (preferred)
- Knowledge of regional specific healthcare systems and clinical practices (preferred)
- Strong communication
- Ability to interpret scientific data
- Knowledge of regional healthcare systems
- Field-based job with 50% travel
- Use of electronic communication tools
- Must be legally authorized to work in the United States without restriction
- Must be willing to take a drug test and post-offer physical (if required)
- Must be 18 years of age or older
Benefits
- Competitive compensation
- Work-life balance
- Networking opportunities
- Mobility
Company overview
Boehringer Ingelheim is a leading global research-driven biopharmaceutical company founded in 1885 and headquartered in Ingelheim am Rhein, Germany. As one of the world's top 20 pharmaceutical companies and the largest privately-owned pharmaceutical firm, it operates across three main business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The company focuses on developing innovative therapies for diseases with high unmet medical needs, including cardiometabolic diseases, oncology, respiratory diseases, immunology, central nervous system disorders, and retinal health. With over 54,500 employees across 78 countries, Boehringer Ingelheim generated approximately €26.8 billion in revenue in 2024. The company maintains a strong research and development network with facilities in Germany, the United States, Austria, Japan, and Switzerland, investing significantly in advancing treatments for both human and animal health. Notable products include Jardiance (empagliflozin) for diabetes, Ofev (nintedanib) for pulmonary fibrosis, Spiriva (tiotropium) for respiratory conditions, and Pradaxa (dabigatran) for anticoagulation therapy.